MARKET

AXGN

AXGN

Axogen Inc
NASDAQ
33.90
-0.61
-1.77%
After Hours: 33.70 -0.2 -0.59% 17:38 02/11 EST
OPEN
34.74
PREV CLOSE
34.51
HIGH
34.74
LOW
30.98
VOLUME
1.15M
TURNOVER
--
52 WEEK HIGH
36.00
52 WEEK LOW
9.22
MARKET CAP
1.70B
P/E (TTM)
-697.5309
1D
5D
1M
3M
1Y
5Y
1D
Axogen Inc. to Report Financial Results and Host Investor Call
Reuters · 1d ago
Axogen Inc. veröffentlicht eine Aktualisierung ihres Finanzkalenders
Reuters · 1d ago
Weekly Report: what happened at AXGN last week (0202-0206)?
Weekly Report · 2d ago
Wasatch Micro Cap Fund Q4 2025 Performance Review
Seeking Alpha · 02/04 13:35
AxoGen (AXGN) Receives a Buy from Canaccord Genuity
TipRanks · 02/02 12:09
Weekly Report: what happened at AXGN last week (0126-0130)?
Weekly Report · 02/02 09:21
Are Biotech And Pharma Stocks Poised To Keep Climbing After Hitting 52-Week Highs?
NASDAQ · 01/27 10:34
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Viking Therapeutics (VKTX)
TipRanks · 01/26 14:03
More
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

Webull offers AxoGen Inc stock information, including NASDAQ: AXGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXGN stock methods without spending real money on the virtual paper trading platform.